These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3388993)
1. [Serum hyaluronic acid and aminoterminal procollagen III peptide in inflammatory and degenerative joint diseases]. Seibel MJ; Raimann S; Seglias J; Lautenschläger J; Müller W Z Rheumatol; 1988; 47(2):98-106. PubMed ID: 3388993 [TBL] [Abstract][Full Text] [Related]
2. [Hyaluronic acid and N-terminal procollagen-III-peptide in the urine in inflammatory and degenerative joint diseases]. Respondek M; Seibel MJ; Lautenschläger J; Müller W Z Rheumatol; 1989; 48(3):117-22. PubMed ID: 2789456 [TBL] [Abstract][Full Text] [Related]
3. [Laminin P1 and procollagen III peptide in serum: activity parameters in chronic inflammatory joint diseases]. Schneider M; Lohmann J; Gerlach U Z Rheumatol; 1988; 47(2):93-7. PubMed ID: 3388992 [TBL] [Abstract][Full Text] [Related]
4. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of extracellular matrix in acute pancreatitis. Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198 [TBL] [Abstract][Full Text] [Related]
6. [Serum type III procollagen N-terminal peptide in patients with collagen diseases]. Aoki A; Hagiwara E; Atsumi Y; Shirai A; Igarashi T; Narita M; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T Ryumachi; 1990 Apr; 30(2):81-4. PubMed ID: 2173157 [TBL] [Abstract][Full Text] [Related]
7. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. Faber J; Hørslev-Petersen K; Perrild H; Lorenzen I J Clin Endocrinol Metab; 1990 Oct; 71(4):1016-21. PubMed ID: 2401705 [TBL] [Abstract][Full Text] [Related]
8. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites. Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985 [TBL] [Abstract][Full Text] [Related]
9. The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis. Kida D; Yoneda M; Miyaura S; Ishimaru T; Yoshida Y; Ito T; Ishiguro N; Iwata H; Kimata K J Rheumatol; 1999 Jun; 26(6):1230-8. PubMed ID: 10381035 [TBL] [Abstract][Full Text] [Related]
10. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. Emlen W; Niebur J; Flanders G; Rutledge J J Rheumatol; 1996 Jun; 23(6):974-8. PubMed ID: 8782125 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974 [TBL] [Abstract][Full Text] [Related]
12. [Serum concentration of hyaluronic acid in healthy populations and patients with rheumatoid arthritis--relationship to clinical disease activity of RA]. Yoshinoya S; Mizoguchi Y; Hashimoto Y; Yamada A; Uchida S; Taniguchi A; Nishioka K; Miyamoto T Ryumachi; 1991 Aug; 31(4):381-90. PubMed ID: 1948454 [TBL] [Abstract][Full Text] [Related]
13. Correlation between serum hyaluronan and disease activity and severity in Thai patients with rheumatoid arthritis. Louthrenoo W; Kongtawelert P; Sivasomboon C; Sukitawut W J Med Assoc Thai; 2001 May; 84(5):622-7. PubMed ID: 11560209 [TBL] [Abstract][Full Text] [Related]
14. Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis. Majeed M; McQueen F; Yeoman S; McLean L Ann Rheum Dis; 2004 Sep; 63(9):1166-8. PubMed ID: 15308530 [TBL] [Abstract][Full Text] [Related]
15. Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome. Werle E; Jäkel HP; Müller A; Fischer H; Fiehn W; Eich W Clin Lab; 2005; 51(1-2):11-9. PubMed ID: 15719700 [TBL] [Abstract][Full Text] [Related]
16. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen. Steinmann B; Superti-Furga A; Joller-Jemelka HI; Cetta G; Byers PH Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989 [TBL] [Abstract][Full Text] [Related]
17. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N; Juillet F; Garnero P Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [TBL] [Abstract][Full Text] [Related]
18. Serum aminoterminal type III procollagen peptide in inflammatory and degenerative rheumatic disorders. Hørslev-Petersen K; Bentsen KD; Junker P; Mathiesen FK; Hansen TM; Lorenzen I Clin Rheumatol; 1988 Mar; 7(1):61-8. PubMed ID: 3261674 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of hyaluronan and proteoglycan in joint disease. Lack of association. Hedin PJ; Weitoft T; Hedin H; Engström-Laurent A; Saxne T J Rheumatol; 1991 Oct; 18(10):1601-5. PubMed ID: 1765988 [TBL] [Abstract][Full Text] [Related]
20. Is bone turnover a determinant of bone mass in rheumatoid arthritis? Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]